BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33711631)

  • 1. The Ability of the Framingham Steatosis Index (FSI) to Predict Non-alcoholic Fatty Liver Disease (NAFLD): A Cohort Study.
    Motamed N; Nikkhah M; Karbalaie Niya MH; Khoonsari M; Perumal D; Ashrafi GH; Faraji AH; Maadi M; Ajdarkosh H; Safarnezhad Tameshkel F; Moradi-Lakeh M; Miri SM; Arsang-Jang S; Zamani F
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101567. PubMed ID: 33711631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran.
    Motamed N; Faraji AH; Khonsari MR; Maadi M; Tameshkel FS; Keyvani H; Ajdarkosh H; Karbalaie Niya MH; Rezaie N; Zamani F
    Clin Nutr; 2020 Feb; 39(2):468-474. PubMed ID: 30922791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of the Framingham steatosis index for cardiovascular risk: a nationwide population-based cohort study.
    Cho YK; Kim M; Kim YJ; Jung CH; Lee WJ; Park JY
    Front Cardiovasc Med; 2023; 10():1163052. PubMed ID: 37534274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis.
    Long MT; Pedley A; Colantonio LD; Massaro JM; Hoffmann U; Muntner P; Fox CS
    Clin Gastroenterol Hepatol; 2016 Aug; 14(8):1172-1180.e2. PubMed ID: 27046482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
    Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
    Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
    Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
    Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end product: A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study.
    Pereira ENGDS; Paula DP; de Araujo BP; da Fonseca MJM; Diniz MFHS; Daliry A; Griep RH
    World J Gastroenterol; 2021 Aug; 27(29):4913-4928. PubMed ID: 34447235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.
    Lu ZY; Cen C; Shao Z; Chen XH; Xu CF; Li YM
    World J Gastroenterol; 2016 Feb; 22(5):1884-90. PubMed ID: 26855548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.
    Hsu CL; Wu FZ; Lin KH; Chen YH; Wu PC; Chen YH; Chen CS; Wang WH; Mar GY; Yu HC
    Clin Transl Gastroenterol; 2019 May; 10(5):1-8. PubMed ID: 31082856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of noninvasive scoring systems for the prediction of nonalcoholic fatty liver disease in metabolic syndrome patients.
    Saokaew S; Kositamongkol C; Charatcharoenwitthaya P; Srivanichakorn W; Washirasaksiri C; Chaiyakunapruk N; Phisalprapa P
    Medicine (Baltimore); 2020 Dec; 99(50):e23619. PubMed ID: 33327335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study.
    Yadav D; Choi E; Ahn SV; Koh SB; Sung KC; Kim JY; Huh JH
    Medicine (Baltimore); 2016 Aug; 95(31):e4447. PubMed ID: 27495073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.
    Motamed N; Rabiee B; Poustchi H; Dehestani B; Hemasi GR; Khonsari MR; Maadi M; Saeedian FS; Zamani F
    Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):31-38. PubMed ID: 27597641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New, Non-Invasive Scale for Steatosis Developed Using Real-World Data From Russian Outpatients to Aid in the Diagnosis of Non-Alcoholic Fatty Liver Disease.
    Maev IV; Samsonov AA; Lazebnik LB; Golovanova EV; Pavlov CS; Vovk EI; Ratziu V; Starostin KM
    Adv Ther; 2020 Nov; 37(11):4627-4640. PubMed ID: 32939691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-laboratory-based self-assessment screening score for non-alcoholic fatty liver disease: development, validation and comparison with other scores.
    Lee YH; Bang H; Park YM; Bae JC; Lee BW; Kang ES; Cha BS; Lee HC; Balkau B; Lee WY; Kim DJ
    PLoS One; 2014; 9(9):e107584. PubMed ID: 25216184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of fatty liver disease scoring systems for ultrasound diagnosed non-alcoholic fatty liver disease in adolescents.
    Wan F; Pan F; Ayonrinde OT; Adams LA; Mori TA; Beilin LJ; O'Sullivan TA; Olynyk JK; Oddy WH
    Dig Liver Dis; 2021 Jun; 53(6):746-752. PubMed ID: 33334704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease.
    Jamali R; Razavizade M; Arj A; Aarabi MH
    World J Gastroenterol; 2016 Jun; 22(21):5096-103. PubMed ID: 27275102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher Serum Uric Acid Level Predicts Non-alcoholic Fatty Liver Disease: A 4-Year Prospective Cohort Study.
    Wei F; Li J; Chen C; Zhang K; Cao L; Wang X; Ma J; Feng S; Li WD
    Front Endocrinol (Lausanne); 2020; 11():179. PubMed ID: 32328031
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemoglobin combined with triglyceride and ferritin in predicting non-alcoholic fatty liver.
    Jiang Y; Zeng J; Chen B
    J Gastroenterol Hepatol; 2014; 29(7):1508-14. PubMed ID: 24628002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.